Table 3. Automated calculated mean for healthy Sattler's and Haller's layer thickness across the Early Treatment Diabetic Retinopathy Study grid ( µm).
Subfield | Sattler's layer | Haller's layer |
central submacular | 87±56 (3–264) | 141±50 (57–237) |
superior inner | 77±51 (13–268) | 144±44 (65–251) |
temporal inner | 71±52 (3–233) | 131±53 (48–255) |
inferior inner | 77±55 (4–246) | 133±47 (48–225) |
nasal inner | 81±60 (1–240) | 133±38 (58–211) |
superior outer | 74±45 (10–243) | 121±33 (70–195) |
temporal outer | 50±45 (4–213) | 103±40 (50–181) |
inferior outer | 65±49 (5–215) | 117±37 (64–180) |
nasal outer | 64±50 (3–203) | 110±35 (66–166) |
Grouped by axial eye length for statistical analysis for the CSM subfielda | ||
Hyperope n = 15 | 114±64 (3–264) | 168±43 (57–236) |
Emmetrope n = 18 | 79±45 (19–165) | 133±46 (70–230) |
Myope n = 12 | 48±35 (3–99) | 104±49 (50–236) |
P valueb | .006 (.004) | .003 (.002) |
Grouped by age (years) for the CSM subfield | ||
< 45 n = 27 | 91±51 | 144±50 |
>45 n = 18 | 70±59 | 125±52 |
Data are expressed in µm and as the mean ± standard deviation (range).
a. Eyes were grouped based on the normal AL variation with refraction and age by myopia: AL≥24.5 mm, emmetropic: 24.5>AL≥23.4 mm or hyperopic:AL<23.4 mm)
b. univariate ANOVA (post-hoc test Tukey for hyperopic and myopic eyes)